Find the latest pharmaceutical market place for formulations enquiry about Midostaurin on PharmaCompass.com.

Various Finished Formulation needed in China [ENA19990]

A CDMO that focuses on the development of various finished formulations, including creams, emulsions, liquids, solutions, films, and OSDs is looking for various finished formulations for commercial purposes. The required quantity is 20,000 boxes - 30,000 boxes.
1. Capecitabine (500 mg) Tablets or Capsules
2. Dasatinib (50 mg) Tablets or Capsules
3. Enzalutamide (160 mg) Tablets or Capsules
4. Nilotinib (200 mg) Tablets or Capsules
5. Imatinib Mesylate (400 mg) Tablets or Capsules
6. Midostaurin (25 mg) Tablets or Capsules
7. Sunitinib Malate (50 mg) Tablets or Capsules
8. Tofacitinib XR (11 mg) Tablets or Capsules
9. Pazopanib (400 mg) Tablets or Capsules
10. Adagrasib (200 mg) Tablets or Capsules
11. Apalutamide (60 mg) Tablets or Capsules
12. Fingolimod (0.5 mg) Tablets or Capsules
13. Nintedanib (150 mg) Tablets or Capsules
14. Valganciclovir (450 mg) Tablets or Capsules

Reply

16 Jul 2024

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA16360]

Specialized Hospital For Active Treatment Of Hematological Diseases Ead is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 22-Feb-2023.
1. Venetoclax (100 mg) Tablets. The required quantity is 17,000,000 units.
2. Midostaurin (25 mg) Capsules. The required quantity is 300,000 units.

Reply

13 Feb 2023